Maria L. Ascierto, Ph.D. Saint John's Cancer Institute
Por um escritor misterioso
Descrição
Saint John's Cancer Institute's Director of Translational Immunology, Maria L. Ascierto, Ph.D. Contact Dr. Ascierto via email or phone number.
Brief Report: Safety and Antitumor Activity of Durvalumab Plus Tremelimumab in Programmed Cell Death-(Ligand)1–Monotherapy Pretreated, Advanced NSCLC: Results From a Phase 1b Clinical Trial - ScienceDirect
Melanoma Symposium - Saint John's Cancer Institute
Calaméo - Activity Report Iuct O 2019
Santa Monica Melanoma Symposium - A CME Event - April 30th, 2022 - Saint John's Cancer Institute
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases
Multi-omic profiling reveals discrepant immunogenic properties and a unique tumor microenvironment among melanoma brain metastases
Melanoma/Skin Cancer Treatment Center - Santa Monica, CA
Antoni Ribas – UCLA Graduate Programs in Bioscience (GPB)
Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation - Yu - 2022 - Advanced Science - Wiley Online Library
de
por adulto (o preço varia de acordo com o tamanho do grupo)
